[Use of a new anti-inflammatory drug in the ORL and maxillofacial domains].
D000893:Anti-Inflammatory Agents; D004194:Disease; D005145:Face; D008437:Maxilla; D010036:Otolaryngology / Q000628:therapy*; D010653:Phenylbutazone / Q000031:analogs & derivatives
D000893:Anti-Inflammatory Agents; D010653:Phenylbutazone
FACE/diseases; MAXILLA/diseases; OTORHINOLARYNGOLOGY/therapy; PHENYLBUTAZONE/related compounds